{"pmid":32354732,"title":"UK neurology response to the COVID-19 crisis.","text":["UK neurology response to the COVID-19 crisis.","COVID-19 has led to seismic changes in neurological practice in a matter of weeks. The Association of British Neurologists has supported neurology specialists and patients during this rapid reorganisation and its attendant challenges. We have written guidance on structured service transformation, considering the need to sustain long term care while responding to acute developments; we have recognised that staff experience differs and that this, as well as individual risk factors should be considered when redeployment occurs. Appreciating that there may be understandable anxiety when facing a working routine outside normal practice, we have signposted ethical and psychological support for individuals. We have also focused on our patients: we have facilitated a national alert system to register all neurological COVID cases, coordinating research efforts on this new disease; finally we have defined how to identify the most vulnerable patients under our care. When this initial wave of the pandemic subsides, we will have planned for return to the new 'norm', ready to embrace innovation where appropriate, aiming to minimise fall-out in our chronic disease population, and potentially having enhanced and modernised our services.","Clin Med (Lond)","Mummery, Catherine J","Kipps, Christopher M","32354732"],"abstract":["COVID-19 has led to seismic changes in neurological practice in a matter of weeks. The Association of British Neurologists has supported neurology specialists and patients during this rapid reorganisation and its attendant challenges. We have written guidance on structured service transformation, considering the need to sustain long term care while responding to acute developments; we have recognised that staff experience differs and that this, as well as individual risk factors should be considered when redeployment occurs. Appreciating that there may be understandable anxiety when facing a working routine outside normal practice, we have signposted ethical and psychological support for individuals. We have also focused on our patients: we have facilitated a national alert system to register all neurological COVID cases, coordinating research efforts on this new disease; finally we have defined how to identify the most vulnerable patients under our care. When this initial wave of the pandemic subsides, we will have planned for return to the new 'norm', ready to embrace innovation where appropriate, aiming to minimise fall-out in our chronic disease population, and potentially having enhanced and modernised our services."],"journal":"Clin Med (Lond)","authors":["Mummery, Catherine J","Kipps, Christopher M"],"date":"2020-05-02T11:00:00Z","year":2020,"_id":"32354732","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.7861/clinmed.2020-0159","keywords":["covid-19","neurology","service reconfiguration","service transformation","workforce deployment"],"locations":["GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1666138495240896513,"score":9.490897,"similar":[{"pmid":32284363,"title":"Acute neurology during the COVID-19 pandemic: Supporting the front line.","text":["Acute neurology during the COVID-19 pandemic: Supporting the front line.","Neurologists are affected by the COVID-19 pandemic in several key ways, including: a reduced ability to admit and accept in transfer critically ill neurologic patients due to census overflow; personal risk of exposure to COVID-19; and potentially redeployment of the acute neurologist workforce towards general medicine to assist our colleagues managing the surge of medical patients. As providers of inpatient and emergency-based acute neurologic care, we have been attempting to locally prepare for and manage the COVID-19 pandemic by focusing on 3 key areas: creating an integrated preparation plan that supports hospital measures; building an optimized, flexible, and redundant workforce; and maintaining a high level of neurologic care in our hospital and across our region despite limited transfer capabilities during the pandemic. This final concern is of key relevance in our region where our tertiary hospital supports numerous smaller community hospitals, typically by providing an open door to patient transfers. These hospitals are often in rural or frontier regions and are also affected by COVID-19, so not only are beginning to experience their own bed and clinician shortages,(1) but are understandably nervous about what the pandemic means for the availability of traditional support systems for other non-COVID-related diseases.","Neurology","Majersik, Jennifer J","Reddy, Vivek K","32284363"],"abstract":["Neurologists are affected by the COVID-19 pandemic in several key ways, including: a reduced ability to admit and accept in transfer critically ill neurologic patients due to census overflow; personal risk of exposure to COVID-19; and potentially redeployment of the acute neurologist workforce towards general medicine to assist our colleagues managing the surge of medical patients. As providers of inpatient and emergency-based acute neurologic care, we have been attempting to locally prepare for and manage the COVID-19 pandemic by focusing on 3 key areas: creating an integrated preparation plan that supports hospital measures; building an optimized, flexible, and redundant workforce; and maintaining a high level of neurologic care in our hospital and across our region despite limited transfer capabilities during the pandemic. This final concern is of key relevance in our region where our tertiary hospital supports numerous smaller community hospitals, typically by providing an open door to patient transfers. These hospitals are often in rural or frontier regions and are also affected by COVID-19, so not only are beginning to experience their own bed and clinician shortages,(1) but are understandably nervous about what the pandemic means for the availability of traditional support systems for other non-COVID-related diseases."],"journal":"Neurology","authors":["Majersik, Jennifer J","Reddy, Vivek K"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32284363","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1212/WNL.0000000000009564","topics":["Prevention"],"weight":1,"_version_":1666138491371651073,"score":204.84073},{"pmid":32358217,"title":"Rapid implementation of virtual neurology in response to the COVID-19 pandemic.","text":["Rapid implementation of virtual neurology in response to the COVID-19 pandemic.","The COVID-19 pandemic is causing world-wide social dislocation, operational and economic dysfunction, and high rates of morbidity and mortality. Medical practices are responding by developing, disseminating and implementing unprecedented changes in health care delivery. Telemedicine has rapidly moved to the frontline of clinical practice due to the need for prevention and mitigation strategies; these have been encouraged, facilitated, and enabled by changes in government rules and regulations and payer-driven reimbursement policies.We describe our neurology department's situational transformation from in-person outpatient visits to a largely virtual neurology practice in response to the COVID-19 pandemic. Two key factors enabled our rapid deployment of virtual encounters in neurology and its subspecialties. The first was a well-established robust information technology infrastructure supporting virtual urgent care services at our institution; this connected physicians directly to patients using both the physician's and the patient's own mobile devices. The second is the concept of one patient, one chart, facilitated by a suite of interconnected electronic medical record (EMR) applications on several different device types.We present our experience with conducting general teleneurology encounters using secure synchronous audio and video connections integrated with an EMR. This report also details how we perform virtual neurological examinations that are clinically meaningful, and how we document, code and bill for these virtual services. Many of these processes can be used by other neurology providers, regardless of their specific practice model. We then discuss potential roles for teleneurology after the COVID-19 global pandemic has been contained.","Neurology","Grossman, Scott N","Han, Steven C","Balcer, Laura J","Kurzweil, Arielle","Weinberg, Harold","Galetta, Steven L","Busis, Neil A","32358217"],"abstract":["The COVID-19 pandemic is causing world-wide social dislocation, operational and economic dysfunction, and high rates of morbidity and mortality. Medical practices are responding by developing, disseminating and implementing unprecedented changes in health care delivery. Telemedicine has rapidly moved to the frontline of clinical practice due to the need for prevention and mitigation strategies; these have been encouraged, facilitated, and enabled by changes in government rules and regulations and payer-driven reimbursement policies.We describe our neurology department's situational transformation from in-person outpatient visits to a largely virtual neurology practice in response to the COVID-19 pandemic. Two key factors enabled our rapid deployment of virtual encounters in neurology and its subspecialties. The first was a well-established robust information technology infrastructure supporting virtual urgent care services at our institution; this connected physicians directly to patients using both the physician's and the patient's own mobile devices. The second is the concept of one patient, one chart, facilitated by a suite of interconnected electronic medical record (EMR) applications on several different device types.We present our experience with conducting general teleneurology encounters using secure synchronous audio and video connections integrated with an EMR. This report also details how we perform virtual neurological examinations that are clinically meaningful, and how we document, code and bill for these virtual services. Many of these processes can be used by other neurology providers, regardless of their specific practice model. We then discuss potential roles for teleneurology after the COVID-19 global pandemic has been contained."],"journal":"Neurology","authors":["Grossman, Scott N","Han, Steven C","Balcer, Laura J","Kurzweil, Arielle","Weinberg, Harold","Galetta, Steven L","Busis, Neil A"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32358217","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1212/WNL.0000000000009677","topics":["Prevention"],"weight":1,"_version_":1666138495353094146,"score":198.31227},{"pmid":32458197,"pmcid":"PMC7250266","title":"Neurological manifestations of COVID-19: a review of what we know so far.","text":["Neurological manifestations of COVID-19: a review of what we know so far.","Coronavirus disease 2019 (COVID-19) has become a pandemic disease globally. While it mostly presents with respiratory symptoms, it has already been found that it could manifest with a series of neurological symptoms as well, either at presentation or during the course of the disease. Symptoms vary from non-specific such as headache or dizziness to more specific such as convulsions and cerebrovascular disease (CVD). This study aims to give an overview of the neurological manifestations of COVID-19 and discuss the potential pathogenetic mechanisms of central nervous system (CNS) involvement. Clinicians and especially internists, neurologists, and infectious disease specialists should be aware of these symptoms and able to recognize them early. Prompt diagnosis and immediate management of the neurological manifestations of the novel coronavirus will not only improve the prognosis of COVID-19 patients but will also prevent the dissemination of the disease due to misdiagnosed cases.","J Neurol","Gklinos, Panagiotis","32458197"],"abstract":["Coronavirus disease 2019 (COVID-19) has become a pandemic disease globally. While it mostly presents with respiratory symptoms, it has already been found that it could manifest with a series of neurological symptoms as well, either at presentation or during the course of the disease. Symptoms vary from non-specific such as headache or dizziness to more specific such as convulsions and cerebrovascular disease (CVD). This study aims to give an overview of the neurological manifestations of COVID-19 and discuss the potential pathogenetic mechanisms of central nervous system (CNS) involvement. Clinicians and especially internists, neurologists, and infectious disease specialists should be aware of these symptoms and able to recognize them early. Prompt diagnosis and immediate management of the neurological manifestations of the novel coronavirus will not only improve the prognosis of COVID-19 patients but will also prevent the dissemination of the disease due to misdiagnosed cases."],"journal":"J Neurol","authors":["Gklinos, Panagiotis"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458197","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s00415-020-09939-5","keywords":["covid-19","coronavirus","neurological manifestations","neurology","sars-cov-2"],"topics":["Diagnosis"],"weight":1,"_version_":1668141322660216832,"score":193.94804},{"pmid":32373652,"pmcid":"PMC7197306","title":"Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID-19 Experience.","text":["Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID-19 Experience.","Background: Although the COVID-19 pandemic is affecting a relatively small proportion of the global population, its effects have already reached everyone. The pandemic has the potential to differentially disadvantage chronically ill patients, including those with Parkinson's disease (PD). The first health care reaction has been to limit access to clinics and neurology wards to preserve fragile patients with PD from being infected. In some regions, the shortage of medical staff has also forced movement disorders neurologists to provide care for patients with COVID-19. Objective: To share the experience of various movement disorder neurologists operating in different world regions and provide a common approach to patients with PD, with a focus on those already on advanced therapies, which may serve as guidance in the current pandemic and for emergency situations that we may face in the future. Conclusion: Most of us were unprepared to deal with this condition given that in many health care systems, telemedicine has been only marginally available or only limited to email or telephone contacts. In addition, to ensure sufficient access to intensive care unit beds, most elective procedures (including deep brain stimulation or the initiation of infusion therapies) have been postponed. We all hope there will soon be a time when we will return to more regular hospital schedules. However, we should consider this crisis as an opportunity to change our approach and encourage our hospitals and health care systems to facilitate the remote management of chronic neurological patients, including those with advanced PD.","Mov Disord Clin Pract","Fasano, Alfonso","Antonini, Angelo","Katzenschlager, Regina","Krack, Paul","Odin, Per","Evans, Andrew H","Foltynie, Thomas","Volkmann, Jens","Merello, Marcelo","32373652"],"abstract":["Background: Although the COVID-19 pandemic is affecting a relatively small proportion of the global population, its effects have already reached everyone. The pandemic has the potential to differentially disadvantage chronically ill patients, including those with Parkinson's disease (PD). The first health care reaction has been to limit access to clinics and neurology wards to preserve fragile patients with PD from being infected. In some regions, the shortage of medical staff has also forced movement disorders neurologists to provide care for patients with COVID-19. Objective: To share the experience of various movement disorder neurologists operating in different world regions and provide a common approach to patients with PD, with a focus on those already on advanced therapies, which may serve as guidance in the current pandemic and for emergency situations that we may face in the future. Conclusion: Most of us were unprepared to deal with this condition given that in many health care systems, telemedicine has been only marginally available or only limited to email or telephone contacts. In addition, to ensure sufficient access to intensive care unit beds, most elective procedures (including deep brain stimulation or the initiation of infusion therapies) have been postponed. We all hope there will soon be a time when we will return to more regular hospital schedules. However, we should consider this crisis as an opportunity to change our approach and encourage our hospitals and health care systems to facilitate the remote management of chronic neurological patients, including those with advanced PD."],"journal":"Mov Disord Clin Pract","authors":["Fasano, Alfonso","Antonini, Angelo","Katzenschlager, Regina","Krack, Paul","Odin, Per","Evans, Andrew H","Foltynie, Thomas","Volkmann, Jens","Merello, Marcelo"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32373652","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/mdc3.12965","keywords":["covid-19","parkinson's disease","sars-cov-2","advanced therapies","telemedicine"],"topics":["Prevention"],"weight":1,"_version_":1666138496490799104,"score":193.435},{"pmid":32419751,"pmcid":"PMC7213032","title":"2019-NCoV: What Every Neurologist Should Know?","text":["2019-NCoV: What Every Neurologist Should Know?","The 2019 novel Corona Virus pandemic beginning from Wuhan, China primarily affects the respiratory tract but its has impacted clinical practice across a range of specialities including neurology. We review the bearing of the 2019 NCoV infection on neurological practice. Neurological manifestations are less common than respiratory manifestations, yet conspicuous, affecting nearly over a third of hospitalized individuals. These may be classified in to early - headache, dizziness, hyposmia and hypogeusia and late - encephalopathy. Rarely but surely, a very small proportion of infected individuals might present with stroke. Certain neurological conditions, including cerebrovascular disease in both China and Italy and dementia in Italy predispose to infection and more severe manifestations, requiring intensive care unit admission. There is no convincing evidence that the manifestations, course and outcome of various neurological disorders is impacted by 2019 nCoV infection. Concerns of an increased risk of febrile seizures offset by a reduced frequency of infection in the paediatric age group. Individuals with multiple sclerosis might potentially experience both true and pseudorelapses. Besides a direct effect, 2019 nCoV has tremendously affected neurological care by disrupting the continuity of care and the availability of neurological medicines worldwide. Neurologists should respond to this challenge by developing and sustaining innovative methods of providing care as well as alerting the society at large to adopt measures to contain the spread of 2019 nCoV.","Ann Indian Acad Neurol","Mahajan, Nitika","Singla, Monika","Singh, Balveen","Sajja, Venkatesh","Bansal, Parth","Paul, Birinder","Goel, Parveen","Midha, Rahul","Bansal, Rajinder","Singh, Gagandeep","32419751"],"abstract":["The 2019 novel Corona Virus pandemic beginning from Wuhan, China primarily affects the respiratory tract but its has impacted clinical practice across a range of specialities including neurology. We review the bearing of the 2019 NCoV infection on neurological practice. Neurological manifestations are less common than respiratory manifestations, yet conspicuous, affecting nearly over a third of hospitalized individuals. These may be classified in to early - headache, dizziness, hyposmia and hypogeusia and late - encephalopathy. Rarely but surely, a very small proportion of infected individuals might present with stroke. Certain neurological conditions, including cerebrovascular disease in both China and Italy and dementia in Italy predispose to infection and more severe manifestations, requiring intensive care unit admission. There is no convincing evidence that the manifestations, course and outcome of various neurological disorders is impacted by 2019 nCoV infection. Concerns of an increased risk of febrile seizures offset by a reduced frequency of infection in the paediatric age group. Individuals with multiple sclerosis might potentially experience both true and pseudorelapses. Besides a direct effect, 2019 nCoV has tremendously affected neurological care by disrupting the continuity of care and the availability of neurological medicines worldwide. Neurologists should respond to this challenge by developing and sustaining innovative methods of providing care as well as alerting the society at large to adopt measures to contain the spread of 2019 nCoV."],"journal":"Ann Indian Acad Neurol","authors":["Mahajan, Nitika","Singla, Monika","Singh, Balveen","Sajja, Venkatesh","Bansal, Parth","Paul, Birinder","Goel, Parveen","Midha, Rahul","Bansal, Rajinder","Singh, Gagandeep"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32419751","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.4103/aian.AIAN_210_20","keywords":["2019 novel corona virus","epilepsy","headache","multiple sclerosis","neurological manifestations","stroke"],"locations":["Wuhan","China","China","Italy","Italy"],"countries":["Italy","China"],"countries_codes":["ITA|Italy","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1667159284502233088,"score":192.03847}]}